In human breast cancer cells (MCF-7), Mireuta and coworkers could demonstrate that the proximal promoter region of IGFBP-2 is activated by an IGF-I/PI3K/AKT/mTOR-dependent manner via an increase of nuclear Sp1 (44). This evidence concerns the gene IGFBP2 and breast carcinoma.